Skip to main content
Clinical Trials/CTRI/2023/06/054488
CTRI/2023/06/054488
Not yet recruiting
Phase 2

A Randomised controlled clinical study to evaluate the efficacy of dashamool shilajit vati in the management of vatashtheela with special refernce to benign prostate hyperplasia

Ayurved seva sangh Ayurved Mahavidyalaya0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N40- Benign prostatic hyperplasia
Sponsor
Ayurved seva sangh Ayurved Mahavidyalaya
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurved seva sangh Ayurved Mahavidyalaya

Eligibility Criteria

Inclusion Criteria

  • Patients with clinical features of BPH like Increases frequency, Weak urinary flow, Urgency of micturation,Nocturia,Straining during micturation and feeling of incomplete emptying of bladder,having post voiding residual volume upto 200 ml,patients willing to participate in clinical trial

Exclusion Criteria

  • diagnosed case of malignancy of prostate, urethral stricture, active UTI, Patients with uncontrolled DM, TB, Malignancy and HBV
  • Patients with imapaired renal function
  • other systemic disorders which can interfere with course of the treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials